Company Filing History:
4 out of 6 
2 out of 11 
2 out of 55 Years Active: 2011-2015
Title: Mai Ito: Innovator in Enzyme Replacement Therapy
Introduction
Mai Ito is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of enzyme replacement therapy, particularly in relation to Fabry disease. With a total of 4 patents, her work focuses on developing highly functional enzymes that can improve patient outcomes.
Latest Patents
One of Mai Ito's latest patents involves a highly functional enzyme that exhibits alpha-galactosidase activity. This enzyme is designed for use in enzyme replacement therapy for Fabry disease. The invention provides a protein that shows no allergic adverse side effects, maintains high stability in blood, and can be easily incorporated into the cells of affected organs. The protein achieves alpha-galactosidase activity by altering the structure of the active site of wild-type human alpha-N-acetylgalactosaminidase.
Career Highlights
Throughout her career, Mai Ito has worked with notable organizations such as Altif Laboratories and the Tokyo Metropolitan Organization for Medical Research. Her innovative research has positioned her as a key figure in the development of therapeutic solutions for genetic disorders.
Collaborations
Mai Ito has collaborated with esteemed colleagues, including Hitoshi Sakuraba and Youichi Tajima. These partnerships have further enhanced her research and contributions to the field.
Conclusion
Mai Ito's work in enzyme replacement therapy represents a significant advancement in the treatment of Fabry disease. Her innovative approach and dedication to research continue to inspire progress in medical science.